140 related articles for article (PubMed ID: 37104007)
21. The high expression of long non-coding RNA PANDAR indicates a poor prognosis for colorectal cancer and promotes metastasis by EMT pathway.
Lu M; Liu Z; Li B; Wang G; Li D; Zhu Y
J Cancer Res Clin Oncol; 2017 Jan; 143(1):71-81. PubMed ID: 27629879
[TBL] [Abstract][Full Text] [Related]
22. Long non-coding RNAs AC026904.1 and UCA1: a "one-two punch" for TGF-β-induced SNAI2 activation and epithelial-mesenchymal transition in breast cancer.
Li GY; Wang W; Sun JY; Xin B; Zhang X; Wang T; Zhang QF; Yao LB; Han H; Fan DM; Yang AG; Jia LT; Wang L
Theranostics; 2018; 8(10):2846-2861. PubMed ID: 29774079
[TBL] [Abstract][Full Text] [Related]
23. Long non-coding RNA HOTTIP promotes hypoxia-induced epithelial-mesenchymal transition of malignant glioma by regulating the miR-101/ZEB1 axis.
Zhang S; Wang W; Liu G; Xie S; Li Q; Li Y; Lin Z
Biomed Pharmacother; 2017 Nov; 95():711-720. PubMed ID: 28886531
[TBL] [Abstract][Full Text] [Related]
24. LncRNA DLX6-AS1 Contributes to Epithelial-Mesenchymal Transition and Cisplatin Resistance in Triple-negative Breast Cancer via Modulating Mir-199b-5p/Paxillin Axis.
Du C; Wang Y; Zhang Y; Zhang J; Zhang L; Li J
Cell Transplant; 2020; 29():963689720929983. PubMed ID: 32686982
[TBL] [Abstract][Full Text] [Related]
25. Overexpression of lncRNA HOXA11-AS promotes cell epithelial-mesenchymal transition by repressing miR-200b in non-small cell lung cancer.
Chen JH; Zhou LY; Xu S; Zheng YL; Wan YF; Hu CP
Cancer Cell Int; 2017; 17():64. PubMed ID: 28615992
[TBL] [Abstract][Full Text] [Related]
26. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
[No Abstract] [Full Text] [Related]
27. LncRNA TUG1 influences papillary thyroid cancer cell proliferation, migration and EMT formation through targeting miR-145.
Lei H; Gao Y; Xu X
Acta Biochim Biophys Sin (Shanghai); 2017 Jul; 49(7):588-597. PubMed ID: 28645161
[TBL] [Abstract][Full Text] [Related]
28. LncRNA CASC2 expression is down- regulated in papillary thyroid cancer and promotes cell invasion by affecting EMT pathway.
Zhou T; Zhong M; Zhang S; Wang Z; Xie R; Xiong C; Lv Y; Chen W; Yu J
Cancer Biomark; 2018; 23(2):185-191. PubMed ID: 30175973
[TBL] [Abstract][Full Text] [Related]
29. Resistin induces breast cancer cells epithelial to mesenchymal transition (EMT) and stemness through both adenylyl cyclase-associated protein 1 (CAP1)-dependent and CAP1-independent mechanisms.
Avtanski D; Garcia A; Caraballo B; Thangeswaran P; Marin S; Bianco J; Lavi A; Poretsky L
Cytokine; 2019 Aug; 120():155-164. PubMed ID: 31085453
[TBL] [Abstract][Full Text] [Related]
30. SNHG1 contributes to proliferation and invasion by regulating miR-382 in breast cancer.
Zheng S; Li M; Miao K; Xu H
Cancer Manag Res; 2019; 11():5589-5598. PubMed ID: 31354360
[No Abstract] [Full Text] [Related]
31. LncRNA XIST promotes pancreatic cancer migration, invasion and EMT by sponging miR-429 to modulate ZEB1 expression.
Shen J; Hong L; Yu D; Cao T; Zhou Z; He S
Int J Biochem Cell Biol; 2019 Aug; 113():17-26. PubMed ID: 31163263
[TBL] [Abstract][Full Text] [Related]
32. Long non-coding RNA ATB promotes growth and epithelial-mesenchymal transition and predicts poor prognosis in human prostate carcinoma.
Xu S; Yi XM; Tang CP; Ge JP; Zhang ZY; Zhou WQ
Oncol Rep; 2016 Jul; 36(1):10-22. PubMed ID: 27176634
[TBL] [Abstract][Full Text] [Related]
33. LncRNA MIR4435-2HG promotes proliferation, migration, invasion and epithelial mesenchymal transition via targeting miR-22-3p/TMEM9B in breast cancer.
Ke J; Wang Q; Zhang W; Ni S; Mei H
Am J Transl Res; 2022; 14(8):5441-5454. PubMed ID: 36105009
[TBL] [Abstract][Full Text] [Related]
34. Long noncoding RNA VIM-AS1 promotes colorectal cancer progression and metastasis by inducing EMT.
Rezanejad Bardaji H; Asadi MH; Yaghoobi MM
Eur J Cell Biol; 2018 May; 97(4):279-288. PubMed ID: 29656793
[TBL] [Abstract][Full Text] [Related]
35. Long non-coding RNA ES1 controls the proliferation of breast cancer cells by regulating the Oct4/Sox2/miR-302 axis.
Keshavarz M; Asadi MH
FEBS J; 2019 Jul; 286(13):2611-2623. PubMed ID: 30927330
[TBL] [Abstract][Full Text] [Related]
36. Long non-coding RNA GHET1 promotes human breast cancer cell proliferation, invasion and migration via affecting epithelial mesenchymal transition.
Song R; Zhang J; Huang J; Hai T
Cancer Biomark; 2018; 22(3):565-573. PubMed ID: 29843220
[TBL] [Abstract][Full Text] [Related]
37. LncRNA ZEB1-AS1 Regulates Colorectal Cancer Cells by MiR-205/YAP1 Axis.
Jin Z; Chen B
Open Med (Wars); 2020; 15():175-184. PubMed ID: 32190742
[TBL] [Abstract][Full Text] [Related]
38. LncRNA TP73-AS1 predicts the prognosis of bladder cancer patients and functions as a suppressor for bladder cancer by EMT pathway.
Tuo Z; Zhang J; Xue W
Biochem Biophys Res Commun; 2018 May; 499(4):875-881. PubMed ID: 29625110
[TBL] [Abstract][Full Text] [Related]
39. Prognostic and predictive value of long non-coding RNA GAS5 and mircoRNA-221 in colorectal cancer and their effects on colorectal cancer cell proliferation, migration and invasion.
Liu L; Meng T; Yang XH; Sayim P; Lei C; Jin B; Ge L; Wang HJ
Cancer Biomark; 2018; 22(2):283-299. PubMed ID: 29630521
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of lncRNA PANDAR reduces cell proliferation, cell invasion and suppresses EMT pathway in breast cancer.
Li Y; Su X; Pan H
Cancer Biomark; 2019; 25(2):185-192. PubMed ID: 31104011
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
